<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The influence of pentoxifylline on <z:mpath ids='MPATH_458'>normal</z:mpath> and diseased neutrophil function has been studied in vitro </plain></SENT>
<SENT sid="1" pm="."><plain>In high concentrations pentoxifylline stimulated human neutrophil chemotaxis toward both <z:mp ids='MP_0001794'>bacterial</z:mp> <z:chebi fb="0" ids="25676">oligopeptides</z:chebi> and complement components </plain></SENT>
<SENT sid="2" pm="."><plain>Pentoxifylline was also shown in vitro to restore the <z:mpath ids='MPATH_458'>normal</z:mpath> chemotactic capacity of neutrophils from patients with known functional defects, i.e. <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, <z:e sem="disease" ids="C0272174" disease_type="Disease or Syndrome" abbrv="">lazy leucocyte syndrome</z:e>, juvenile <z:e sem="disease" ids="C0031099" disease_type="Disease or Syndrome" abbrv="">parodontitis</z:e>, <z:e sem="disease" ids="C0022398" disease_type="Disease or Syndrome" abbrv="HIES">hyper-IgE-syndrome</z:e> and liver <z:hpo ids='HP_0001394'>cirrhosis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Pentoxifylline was also shown to strongly inhibit the release of primary and secondary granule release of granulocytes </plain></SENT>
<SENT sid="4" pm="."><plain>Moreover, pentoxifylline inhibits both basal and stimulated neutrophil <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to both aortic and pulmonary artery calf endothelium </plain></SENT>
<SENT sid="5" pm="."><plain>The mechanism whereby pentoxifylline exerts this action is not adequately understood </plain></SENT>
<SENT sid="6" pm="."><plain>While our results partially imply interference of pentoxifylline with neutrophil cyclic <z:chebi fb="47" ids="16027,28971">AMP</z:chebi> and/or <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> metabolism, down-regulation of neutrophil functional antigen (e.g. CD11, CD18) expression seems to play a key role in the observed drug effects </plain></SENT>
<SENT sid="7" pm="."><plain>Finally, these results indicate that pentoxifylline may be useful in the treatment of granulocyte mediated diseases and symptoms </plain></SENT>
</text></document>